Get started

Penny

TAT Breakout Pending When it comes to trading stocks, even veteran investors are prone to making mistakes. Investors will often get bombarded with stock tips touting the next breakout star. Following these tips without fully looking into the situation can wind up being a huge mistake. If even one person knows about the next big stock, chances are many other people already do as well. The reading from the 40-day commodity channel index is currently Hold but it is rising. The 100-day moving average verse price signal is Buy
T
by SoWaVvY
CPHI Win or Fail? (Fib with RSI and Ghost bars)Lets see what next week will bring! After a recent check, the 14-day RSIfor China Pharma Holdings (CPHI) is currently at 65.41, the 7-day stands at 78.81, and the 3-day is sitting at 94.30.Many professionals agree that realizing a loss is just as important as picking a winner, so I've also included a potential loss area to point out my opinion of when to abort mission. Price Target is anywhere form 0.60 to 0.72 by mid week. The stock has returned 21.95% weekly, which was maintained at 9.59% in the 1-month period. I'm looking forward to the upside of that return!
AMEX:CPHIShort
by SoWaVvY
Penny stocks: Novacyt (1/5) + Education, Spread your investmentsRisk: Medium Please be advised that this is only an idea, so you are responsible for any losses yourself. Dear followers, First of all, many thanks for following and liking my ideas. As promised I provide you with some penny stocks today, but for the most part I keep focusing on the crypto analyses. Education: Do you know people who had to leave their home because they could no longer pay their mortgage after losing a job? I do. No matter how bad it is for them, these people have made a mistake at an earlier stage. Probably out of ignorance. Did you hear the stories about people who lost their money in the stock market in 2002 and went to drugs? I do. What if the crypto market crashes? Have you lost all your money? Then you made exactly the same mistake. The trick is to create multiple cash flows. A job, maybe two or trhee jobs, cryptos, currencies, interest, stocks, dividends, et cetera. When one or two cash flows are lost, you can still continue to live in your house. Otherwise you have still made a mistake by buying an overpriced house that you actually could not afford. This is why I provide you today with 5 penny stocks that are technically right, about to break out and have a great profit potential for the coming years. Imagine one of these companies is a sleeping giant? Two shares rise a little, one falls and one company goes bankrupt? By spreading your investments you still have the jackpot and you have perhaps made a 1000% return or more! Stock The first penny stock is Novacyt. The Novacyt Group is a leader in the field of cellular diagnostics with a growing portfolio of cancer and infectious disease products and services. Novacyt is ready for a breakout. We have seen one false breakout already. If we close with a candle above the blue trendline a breakout is confirmed. (Click the play button on the chart to look for confirmation) Our first target will be the 200ma, but I've this stock in my long-term portfolio. Buy: Now or if it breaks out. Please, follow and like for more trading ideas. Questions? Feel free to ask and your feedback is welcome!
EURONEXT:ALNOVLong
by Trades999
Penny stocks: RoodMicrotec (5/5) Education + Spread!Risk: Medium Please be advised that this is only an idea, so you are responsible for any losses yourself. Dear followers, First of all, many thanks for following and liking my ideas. As promised I provide you with some penny stocks today, but for the most part I keep focusing on the crypto analyses. Education: Do you know people who had to leave their home because they could no longer pay their mortgage after losing a job? I do. No matter how bad it is for them, these people have made a mistake at an earlier stage. Probably out of ignorance. Did you hear the stories about people who lost their money in the stock market in 2002 and went to drugs? I do. What if the crypto market crashes? Have you lost all your money? Then you have made exactly the same mistake. The trick is to create multiple cash flows. A job, maybe two or trhee jobs, cryptos, currencies, interest, stocks, dividends, et cetera. When one or two cash flows are lost, you can still continue to live in your house. Otherwise you have still made a mistake by buying an overpriced house that you actually could not afford. This is why I provide you today with 5 penny stocks that are technically right, about to break out and have a great profit potential for the coming years. Imagine one of these companies is a sleeping giant? Two shares rise a little, one falls and one company goes bankrupt? By spreading your investments you still have the jackpot and you have perhaps made a 1000% return or more! Stock The fifth and last penny stock is RoodMicrotec. I'm in this stock since 0.21 and I just increased my position. We already broke out the old channel and we are trading in a new channel now (upwards). Buy: Now or at the bottom of the channel. Please, follow and like for more trading ideas. Questions? Feel free to ask and your feedback is welcome!
RLong
by Trades999
BVTKBravatek is continuing downward and is in desperate need of support. As of late the BVTK twitter has been hinting at big deals coming to fruition any time now. Now the questions to ask, can you afford to wait? With BVTK skidding back towards its humble beginnings in the land of .000s many are starting to lose patience, not to mention money. If BVTK does not find support in the .0016 area, then its time to face the facts that it is 4th and long, and it is better to punt and play another day.
OTC:BVTK
by machinelearnt
BVTK bounce BVTK dipped as low as .0025 in today's session, and then rallied to close at up to an impressive .0034. BVTK is still riding the up trend line, and as you can see on the chart the .0040 price is the 38.2% Fibonacci level. If BVTK can break through and resolve the 38.2% Fibonacci level, I expect there to be rapid upward movement (2nd green arrow above the .0040 level). This stock is VERY volatile obviously, and any news/tweets/financial released by BVTK or Dark Pulse could rip the share price one way or another. I am still bullish on BVTK in the long run. Be careful not to panic sell, as you can see many did in the past few days. Cheers and happy trading!
OTC:BVTKLong
by machinelearnt
$ORRV COMPLETES MERGER WITH $25 - $50 MIL REVENUE COMPANY$25 Million to $50 Million Revenue Generating Company??? YES PLEASE!!! i.imgur.com 1. Merger with McCusker which shows $25 Million to $50 Million of REVS on ZOOM INFO 2. No lawsuits, arbitrations, proceedings, pending investigations, outstanding options, warrants, rights, calls, commitments, conversion rights, plans or other agreements of any character providing for the purchase, issuance or sale of, or any securities convertible into, capital stock of ORRV. 3. 250 Employees 4. Acquisition of Nationwide Tech Services Inc on April 24th 5. 1 HQ and 4 Corporate Offices 6. 9 Subsidiaries (With the acquisition of Nationwide next week) 7. One subsidiary alone Service USA, has almost $2 mil in Net Income. Overview of the 9 subsidiaries for McCusker Holding Corp.: 1/ Mc Cusker & Company Inc. 2/ Service USA, Inc. 3/ 13 enterprises LLC 4/ Computer Tree Inc. 5/ Mc Cusker and Company of the Caribbean (the international division) 6/ Mc Cusker Service Group Inc. 7/ Mc Cusker West inc. 8/ Evergreen Underwriting Group Inc. 9/ Nationwide Tech (Newest Addition) scontent-iad3-1.xx.fbcdn.net
OLong
by StockGuild
1
$OWCP Bullish Pennant Formation with Upcoming MJ Catalysts News ANNUAL REPORT CLARIFICATION FOR SHAREHOLDERS: 1) Page 5: Don't get confused by the OWCP already done Psoriasis study (where efficacy results are imminent) and next deeper and extended studies planned from April: "On February 1, 2017, following the very encouraging results that have been achieved at the mid-point of the Study, the Company determined to extend the size and scope of the Study for the purpose, among other things, of checking the biological markers that have been generated to date with respect to the treatment of psoriasis (proliferation/ inhibition and several interleukins). Despite extending its size and scope of the Study, the Registrant expects to compete the Study during the 2 nd or 3 rd quarters of 2017." The study already done is confirmed in page 36: "We have been conducting a study on the efficacy of the cannabinoid-based topical cream for the treatment of skin conditions generally and psoriasis specifically, which commenced in November, 2016 " While the extended study to start in April 2017 according to previous 8K is the safety phase and identification of biological markers useful to identify potential other application of the cream (Skin Cancer imo): "We started safety phase at the hospital by this month, April 2017, and already planning a unique multi-center efficacy study. This is the natural development of the next generation of safe and tested cannabinoids treatments" 2) Page 5-6: Multiple Myeloma Amazing News for Shareholders is here: "Dr. Leiba led our in vitro studies on the effect of a formulation comprised of Cannabidiol (CBD) and tetrahydrocannabinol (THC) on multiple myeloma cells studied outside their normal biological context. The results indicated a 100% mortality rate of myeloma cells in 80% of the cultured cells within a 24 to 48-hour period, and highlight the potential abilities of cannabis oil extract to fight multiple myeloma cancer cells. We believe that the results of this study indicate a potential to develop a more effective treatment for multiple myeloma than standard therapies." "Expect to submit a clinical trial protocol to the Israeli Institutional Review Board and received its approval to commence a clinical study" "Intend to commence a clinical study in the third quarter of 2017" 3) Notes on competition page 7: For Psoriasis they aim to attack Big Pharma market and they are well aware of current products and thier limitation: "The current common treatments for psoriasis include topical and systemic drugs, steroids, immunosuppressive drugs such as Cyclosporine A (by Novartis), methotrexate or MTX and biological drugs such as Enbrel (by Amgen), Amevive (by Biogen but whose patent expired in 2013) and Ustakinumabn (by Janssen Immunology)." This is excelent Marketing strategic approach; 4) Page 8: Provisional Patents are listed in report, can be downloaded through reference number and are real! They are extremely well written in a professional way and full of interesting claims: when needed (close to deadline) they will pay the service fees and transform them in Official US Permanent Patent; Why to do it before if the provisional is free of charge? Smart approach; 5) Page 12: CERTIFICATION and FDA approval all diligently work has been done according to standard: " Israel’s Ministry of Health, which regulates medical testing, has adopted protocols that correspond, generally, to those of the FDA and the EMA, making it comparatively straightforward for studies conducted in Israel to satisfy FDA and the European Medicines Agency requirements, thereby enabling medical technologies subjected to clinical trials in Israel to reach U.S. and EU commercial markets in an expedited fashion. Many members of Israel’s medical community have earned international prestige in their chosen fields of expertise and routinely collaborate, teach and lecture at leading medical centers throughout the world. Israel also has free trade agreements with the United States
OTC:OWCPLong
by StockGuild
$MMEX 8K Out, 50,000bpd Facility, Contracts/Permits/MovementSenator Ted Cruz’s Endorsement for the Oil and Gas Industry is Timely oilmanmagazine.com 2) Awesome News per 8K. Here it is 4/17/2017 8K www.otcmarkets.com 3) MAYOR CONFIRMS PLANS OF MMEX's REFINERY! HERE'S PROOF: investorshub.advfn.com Email confirmation from Lisa D Amato with the Texas Commission on Environmental Quality Air Permits Division. MMEX confirmation of permit submittal in Texas www.dropbox.com $MMEX is going to start trading $1.00+ before you know it.
OTC:MMEXLong
by StockGuild
$USRM From .0045 Onwards She is Ready for the 4th Leg UpBy far one of my top 3 favorite stocks so far this year, our Bio baby has proven her stamina. She has hit the .08 support at triple bottom and is ready for a 4th massive move upwards. With Institutional investors now throwing upwards of $5 million in financing at her for a stake in what is to be a potential FDA approval after a more than likely RMAT approval, its no wonder she is up almost 20,000% as of today from where we first found her. This is a perfect time to get back in if you already sold and are looking for another entry point for the next leg up.
OTC:USRMLong
by StockGuild